| Autor: |
George N; College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman., AbuKhader M; College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman., Al Balushi K; College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman., Al Sabahi B; College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman., Khan SA; College of Pharmacy, National University of Science and Technology, Muscat, Sultanate of Oman. |
| Jazyk: |
angličtina |
| Zdroj: |
Nutritional neuroscience [Nutr Neurosci] 2023 Oct; Vol. 26 (10), pp. 975-996. Date of Electronic Publication: 2022 Sep 20. |
| DOI: |
10.1080/1028415X.2022.2121092 |
| Abstrakt: |
Alzheimer's disease (AD) is a progressive neurodegenerative disease that still has no permanent cure. The drugs prescribed in the present days are only for symptomatic relief for the patients. Many studies correlating the reduction in the incidence of AD with the diet consumed have been published. These studies showed that a diet rich in polyphenols is associated with a decrease in the incidence of AD. The present review is focused on the ability of pomegranate and its bioactive components to ameliorate the progression of AD and their ability to exert a neuroprotective effect. Various studies showing the ability of pomegranate in inhibiting enzymes, reducing reactive oxygen species, inhibition of microglial activation, inhibition of tau protein hyperphosphorylation, maintenance of synaptic plasticity, anti-inflammatory activity and its ability to inhibit Beta secretase-1 (BACE-1) has been reviewed in this article. In spite of the lack of studies on humans, there are compelling evidence indicating that pomegranate can reduce various risk factors involved in the causation of AD and thus can be used as a persistent nutraceutical to slow ageing and for providing neuroprotection for the treatment of AD. Highlights An overview of traditional and pharmacological uses of pomegranate (POM).Potential of POM in the treatment of neurodegenerative diseases especially in AD.Insight into the molecular mechanisms of neuroprotective effects of POM in AD.Clinical evaluation studies involving POM and its bioactive components. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
